Fredun Pharmaceuticals Statistics

Total Valuation

BOM:539730 has a market cap or net worth of INR 3.34 billion. The enterprise value is 4.69 billion.

Market Cap	3.34B
Enterprise Value	4.69B

Important Dates

The next estimated earnings date is Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:539730 has 4.70 million shares outstanding. The number of shares has increased by 0.86% in one year.

Current Share Class	n/a
Shares Outstanding	4.70M
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	56.84%
Owned by Institutions (%)	1.60%
Float	2.03M

Valuation Ratios

The trailing PE ratio is 17.60.

PE Ratio	17.60
Forward PE	n/a
PS Ratio	0.82
PB Ratio	2.55
P/TBV Ratio	2.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	24.95
EV / Sales	1.16
EV / EBITDA	9.70
EV / EBIT	10.69
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.05
Debt / EBITDA	2.84
Debt / FCF	n/a
Interest Coverage	2.51

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	15.86M
Profits Per Employee	734,305
Employee Count	256
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.15% in the last 52 weeks. The beta is 0.85, so BOM:539730's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-22.15%
50-Day Moving Average	684.55
200-Day Moving Average	738.05
Relative Strength Index (RSI)	57.62
Average Volume (20 Days)	4,265

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:539730 had revenue of INR 4.06 billion and earned 187.98 million in profits. Earnings per share was 40.35.

Revenue	4.06B
Gross Profit	919.75M
Operating Income	438.65M
Pretax Income	260.68M
Net Income	187.98M
EBITDA	483.40M
EBIT	438.65M
Earnings Per Share (EPS)	40.35

Full Income Statement

Balance Sheet

The company has 17.30 million in cash and 1.37 billion in debt, giving a net cash position of -1.35 billion or -288.18 per share.

Cash & Cash Equivalents	17.30M
Total Debt	1.37B
Net Cash	-1.35B
Net Cash Per Share	-288.18
Equity (Book Value)	1.31B
Book Value Per Share	277.16
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.66%, with operating and profit margins of 10.80% and 4.63%.

Gross Margin	22.66%
Operating Margin	10.80%
Pretax Margin	6.42%
Profit Margin	4.63%
EBITDA Margin	11.91%
EBIT Margin	10.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.70
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	-0.76%
Earnings Yield	5.63%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a